Dr. Reddy's Inks Deal To Exit Namenda Pay-For-Delay Suit
Drug buyers asked a New York federal court on Monday to approve their deal with generic-drug maker Dr. Reddy's Laboratories to settle class allegations accusing the company of conspiring with other...To view the full article, register now.
Already a subscriber? Click here to view full article